Client Story

hg medical

hg medical is a vertically integrated contract manufacturer for orthopedic implants which supports large medical technology companies in the technical implementation of product innovations, development services and individual customer solutions. 

 

Within a competitive M&A process, hg medical group was up for sale by the former shareholders with hg Darco Group LLC as the former majority shareholder. We were mandated to structure the financing solution and to manage a competitive debt financing process in order to secure optimal financing conditions for the transaction.

Debt and Capital Advisory
Healthcare and Life Sciences
Reading Time 3 Minutes
Key Results
Optimal acquisition financing conditions
during a competitive financing process secured.
Future organic and inorganic growth
of hg medical group enabled.
Successful acquisition
of hg medical group by Nord Holding during a competitive M&A process.

The challenge

  • Within a competitive M&A process hg medical group was up for sale by the former shareholders with hg Darco Group LLC as the former majority shareholder.
  • Within the transaction the German hg medical GmbH and US based hg medical LLC have jointly been sold as hg medical group, now majority-owned by Nord Holding and its related funds.
  • Due to the competitive and short-timed M&A process and the cross- border business model of the group with significant US sales, demands for an optimal acquisition financing solution were complex.
  • Therefore, we were mandated to structure the financing solution and to manage a competitive debt financing process in order to secure optimal financing conditions for the transaction.
Male doctor reviewing a lung radiography.

The solution

  • Structured an optimal acquisition financing solution and managed competitive debt financing process.
  • Ensured financing solution is well-fitted to business model.
  • Lender education and management of due diligence process to ensure bankable due diligence reports, tailor-made to specific needs of acquisition lenders.
  • Secured financing in a short-timed process, meeting tough timelines.
  • Provided a competitive edge to Nord Holding during acquisition process by best-market terms financing package, enabling Nord Holding to in turn provide most attractive acquisition bid during M&A process.
They have played a vital role in providing a tailored financing solution in a complex cross-border transaction. We have been very pleased with the ongoing support and deep expertise the team has showcased throughout the entire, tight-knit process. We want to thank the team and are looking forward to future engagements.
Ronald Grott
Member of the Investment Committee of hg medical

Passion for resultsWhat our 
client says

Ready for tomorrow?Get in touch and see how our team can help you.

What's new?You might also be interested in...

Insight
Article
April 2026
The Map Before the Storm
Is PE Looking at the Right AI Risk?
Insight
Article
April 2026
The strategic thesis was right. The P&L disagrees. Where to look
In private equity, value erosion rarely comes from a fundamentally flawed thesis. More often, the thesis, the priorities, and the operating model simply fail to align — quickly enough, or tightly enough — during the hold period. In tech-enabled industrials, that gap tends to be wider, more persistent, and more expensive to recover from
Insight
Brochure
April 2026
M&A Industry Snapshot: The European PropTech and ConTech M&A market
The European PropTech and ConTech M&A market is regaining momentum, but under fundamentally changed dynamics. Capital has become more selective, strategic buyers are increasingly dominating transaction processes, and single-point solutions are losing relevance despite strong growth.This snapshot highlights a clear shift toward scalable SaaS platforms with recurring revenues, deep workflow integration, and strong data foundations. Buy-and-build strategies remain the primary growth lever for investors, while AI-enabled platforms combining operational data and automation capabilities are commanding increasing strategic premiums.As recent transactions such as the Consigli deal demonstrate, valuation is no longer driven by revenue alone, but by a company’s role within future platform ecosystems. As a result, well-positioned platforms benefit from an attractive exit environment, while demand for mid-market add-on acquisitions remains strong.